(lp0
S'Shareholder Alert: Monteverde &amp; Associates PC Announces An Investigation Of ... PR Newswire  - 20 hours ago NEW YORK, March 17, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde &amp; Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating FBR &amp; Co. (&quot;FBR&quot; or the&nbsp;...'
p1
aS"Los Angeles company acquiring FBR &amp; Co. in $160.1M stock deal L.A. Biz - Feb 21, 2017 Arlington-based FBR &amp; Co., the region's only major homegrown investment bank, has agreed to be acquired by Los Angeles-based B. Riley Financial Inc. in a $160.1 million stock deal, the companies announced Tuesday morning.B. Riley Financial acquiring FBR &amp; Co. in $160 million deal - HousingWireB. Riley Financial  to Acquire FBR &amp; Co  in $160.1M Deal - StreetInsider.com"
p2
aS'The BFD: B. Riley buys FBR &amp; Co. Axios - Feb 21, 2017 B. Riley Financial  on Tuesday said that it has agreed to acquire FBR &amp; Co. , an Arlington, Va.'
p3
aS'BRIEF-B. Riley Financial to acquire FBR &amp; CO in a transaction valued at $160.1 mln Reuters - Feb 21, 2017 b. Riley financial to acquire FBR &amp; co. To form dynamic financial services firm with unmatched capabilities. * b. Riley financial inc says FBR shareholders to receive an anticipated $8.50 special dividend.'
p4
aS'FBR &amp; Co.  By The Numbers: Valuation in Focus Business Review - 16 hours ago FBR &amp; Co.  has an ERP5 rank of 11838. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.'
p5
aS'Honing in on This Dividend Stock: FBR &amp; Co.  Business Review - 17 hours ago Shares of FBR &amp; Co.  currenty have a 10 year dividend growth rate of 0.00000. This number is calculated using the geometric average which provides the typical value of dividend growth over the specified period using the product of their&nbsp;...'
p6
aS'Biotech Targets in Prime Merger Environment - FBR &amp; Co StreetInsider.com - Mar 6, 2017 FBR &amp; Co sees strong appeal for the following potential primary targets for others firms that may be looking to make acquisitions: Tesaro , Agile Therapeutics , Kite Pharma , Juno Therapeutics (NASDAQ:&nbsp;...'
p7
aS"Analyst Activity  FBR &amp; Co Reiterates Outperform on Conatus Pharmaceuticals ... Market Exclusive - Mar 15, 2017 Conatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease.Conatus Pharmaceuticals'  Outperform Rating Reaffirmed at FBR &amp; Co - Chaffey Breeze"
p8
aS'Regions Financial reiterated as Outperform By FBR &amp; Co Normangee Star - 8 hours ago Average Revenue Estimate for the current quarter is $2.21 Billion, according to consensus forecast of 5 analysts. According to their observations and findings, the stock could provide a high EPS of $0.25/share and a Low EPS of $0.22/share.Regions Financial Corp  Forecasted to Post Q2 2017 Earnings of $0.25 Per Share - Chaffey Breeze'
p9
aS'Analyst Activity  FBR &amp; Co Initiates Coverage On Bill Barrett  With ... Market Exclusive - Mar 12, 2017 Today, FBR &amp; Co initiated coverage on Bill Barrett  with a Mkt Perform with a price target of $6.00. There are 6 hold ratings, 6 buy ratings on the stock.FBR &amp; Co Begins Coverage on Bill Barrett Co.  - The Cerbat Gem'
p10
a.